Product Program year 2019 Source: CMS Open Payments

Asthma - Disease

Drug

Open in the dashboard

General payments

$11,226

242 payments

Research payments

$0

0 payments

Through program year 2019, $11,226 in general payments and $0 in research payments were reported against Asthma - Disease.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $11,226 242

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $11,226 242 payments
Top recipients General payments · program year 2019
  1. Ujwala Kaza Allergy & Immunology · New York, NY $282 3% · 4 payments
  2. Cristina Ramos Allergy & Immunology · San Juan, PR $188 2% · 2 payments
  3. Juan Portela Arraiza Otolaryngology · Manati, PR $188 2% · 2 payments
  4. Jose Busquets Otolaryngology · San Juan, PR $188 2% · 2 payments
  5. Hans Sander Dermatology · Austin, TX $178 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Allergy & Immunology $4,957 46% · 81 practitioners
  2. Otolaryngology $1,588 15% · 22 practitioners
  3. Pulmonary Disease Internal Medicine $1,533 14% · 25 practitioners
  4. Allergy Allergy & Immunology $679 6% · 15 practitioners
  5. Allergy & Immunology Internal Medicine $414 4% · 6 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $2,731 24% · 52 recipients
  2. Puerto Rico $1,662 15% · 15 recipients
  3. Virginia $1,159 10% · 13 recipients
  4. Pennsylvania $763 7% · 12 recipients
  5. Georgia $763 7% · 15 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

242 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record